Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

Fig. 4

Association of ETS with HRQOL according to the baseline symptom status. A) The least squares means of the score at each time point throughout the study period for GHS/QOL, social functioning, and emotional functioning. B) The least squares means of the score change from baseline to 8 weeks after initiation of treatment for GHS/QOL, social functioning, and emotional functioning

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us